2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Hyperglycemia in 1 studies
2,2-bis(4-glycidyloxyphenyl)propane: structure
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yamauchi, T | 1 |
Waki, H | 1 |
Kamon, J | 1 |
Murakami, K | 1 |
Motojima, K | 1 |
Komeda, K | 1 |
Miki, H | 1 |
Kubota, N | 1 |
Terauchi, Y | 1 |
Tsuchida, A | 1 |
Tsuboyama-Kasaoka, N | 1 |
Yamauchi, N | 1 |
Ide, T | 1 |
Hori, W | 1 |
Kato, S | 1 |
Fukayama, M | 1 |
Akanuma, Y | 1 |
Ezaki, O | 1 |
Itai, A | 1 |
Nagai, R | 1 |
Kimura, S | 1 |
Tobe, K | 1 |
Kagechika, H | 1 |
Shudo, K | 1 |
Kadowaki, T | 1 |
1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Hyperglycemia
Article | Year |
---|---|
Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
Topics: 3T3 Cells; Adipose Tissue; Animals; Benzhydryl Compounds; Benzoates; Biphenyl Compounds; Diabetes Me | 2001 |